Multilaw Ranked Leading Law Firm

January 2020

Chambers is the leading international directory ranking participants in the legal profession around the world.

The Chambers Asia-Pacific 2020 directory has recently ranked Multilaw, an international network of law firms that Lowndes represents in New Zealand, in Band 1 for Leading Law Firm Networks in the Asia-Pacific Region, one of only 5 international networks in this band.

On a global level, Multilaw has the top “Chambers Global Elite” status alongside only 8 other global networks.

We believe the laser-like focus on the quality of the member firms it admits and retains is a key reason Multilaw maintains its top rankings in the Chambers directories. Multilaw has a truly global presence which sets it apart from the large networks which are US centric with a global reach.

Lowndes is very active in the Multilaw network as the sole NZ representative and Mark Lowndes was a recent global Chair. During his term he travelled to 60 cities in 40 countries around the world representing Multilaw.  The network’s insistence on standards of excellence both in product and service is well aligned with our own, and for that reason this network has offered our clients the safe hands they expect from us, worldwide.

If you are requiring international legal assistance please speak to us about how Lowndes can help.


Chambers 2020 Leading Law Firm Networks in Asia-Pacific Region

Band 1
Lex Mundi
Pacific Rim Advisory Council
World Law Group
World Services Group

Band 2
ALFA International
Employment Law Alliance
First Law International

Band 3
Ally Law
SCG Legal


Lowndes is an award winning corporate and commercial law firm with offices in the heart of Auckland and Wellington. The firm serves local and international companies and investors doing business in New Zealand.

We are recognised for our technical expertise and exceptional client service including high levels of responsiveness and reliability, accessibility of our lawyers, and an unwavering focus on what matters – our clients’ commercial outcomes.